{"entity":{"type":"insider","cik":"0002061679","url":"/insider/0002061679","json_url":"/insider/0002061679.json","name":"Gaskins Tammi L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2025-05-20","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"Gaskins Tammi L","source":"filing","n_filings":4,"first_seen":"2025-05-20","last_seen":"2026-02-25"}],"transactions":[{"id":5893878,"accession":"0001193125-26-071500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-071500","line_url":"/filing/0001193125-26-071500#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002061679","owner_name":"Gaskins Tammi L","owner_display_name":"Gaskins Tammi L","owner_url":"/insider/0002061679","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11239.0,"shares_display":"11,239","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":41134.74,"total_display":"41,134.74","total_whole":"41,135","shares_owned_after":213738.0,"shares_owned_after_display":"213,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":5893876,"accession":"0001193125-26-071500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-071500","line_url":"/filing/0001193125-26-071500#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002061679","owner_name":"Gaskins Tammi L","owner_display_name":"Gaskins Tammi L","owner_url":"/insider/0002061679","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10287.0,"shares_display":"10,287","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":39193.47,"total_display":"39,193.47","total_whole":"39,193","shares_owned_after":224977.0,"shares_owned_after_display":"224,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":4906362,"accession":"0001193125-25-288086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-288086","line_url":"/filing/0001193125-25-288086#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002061679","owner_name":"Gaskins Tammi L","owner_display_name":"Gaskins Tammi L","owner_url":"/insider/0002061679","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6016.0,"shares_display":"6,016","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":19973.12,"total_display":"19,973.12","total_whole":"19,973","shares_owned_after":235264.0,"shares_owned_after_display":"235,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4195940,"accession":"0000950170-25-108016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-108016","line_url":"/filing/0000950170-25-108016#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002061679","owner_name":"Gaskins Tammi L","owner_display_name":"Gaskins Tammi L","owner_url":"/insider/0002061679","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1316.0,"shares_display":"1,316","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":1105.44,"total_display":"1,105.44","total_whole":"1,105","shares_owned_after":241280.0,"shares_owned_after_display":"241,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4526773,"accession":"0000950170-25-075183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-075183","line_url":"/filing/0000950170-25-075183#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0002061679","owner_name":"Gaskins Tammi L","owner_display_name":"Gaskins Tammi L","owner_url":"/insider/0002061679","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2563.0,"shares_display":"2,563","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":1486.54,"total_display":"1,486.54","total_whole":"1,487","shares_owned_after":242596.0,"shares_owned_after_display":"242,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (Chief Commercial Officer)","n_filings":4,"first_seen":"2025-05-20","last_seen":"2026-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002061679","retrieved_at":"2026-08-22T20:49:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}